本文選題：月經(jīng)過少 + 王氏術(shù)黃調(diào)經(jīng)合劑　； 參考：《山西中醫(yī)學(xué)院》2016年碩士論文

【摘要】：目的觀察王氏術(shù)黃調(diào)經(jīng)合劑治療脾腎兩虛型月經(jīng)過少的臨床療效,為臨床應(yīng)用提供理論支持和科學(xué)依據(jù)。方法將符合標(biāo)準(zhǔn)的80例患者按照隨機(jī)數(shù)字表法分為治療組和對(duì)照組各40例,采用單盲法分別給予王氏術(shù)黃調(diào)經(jīng)合劑和夏氏健脾溫腎湯治療。兩組均以一個(gè)月經(jīng)周期為一個(gè)療程,治療三個(gè)療程。觀察患者治療前后月經(jīng)量的恢復(fù)情況,臨床癥狀、體征的改善情況,子宮內(nèi)膜、BBT的的變化情況及藥物的副作用。結(jié)果1.臨床總療效比較:經(jīng)過三個(gè)療程的治療,治療組總有效率為97.5%,對(duì)照組總有效率為92.5%,兩組臨床總療效比較P=0.049(P0.05),差異有統(tǒng)計(jì)學(xué)意義,治療組優(yōu)于對(duì)照組。2.月經(jīng)量積分比較:兩組治療前比較P=0.812(P0.05),差異無統(tǒng)計(jì)學(xué)意義,具有齊同可比性。兩組治療后分別進(jìn)行治療前后比較P=0.000(P0.01),差異有統(tǒng)計(jì)學(xué)意義,說明兩組藥物均能使月經(jīng)量增加。且兩組治療后比較P=0.017(P0.05),差異有統(tǒng)計(jì)學(xué)意義,說明治療組對(duì)月經(jīng)量的增加優(yōu)于對(duì)照組。3.中醫(yī)證候積分比較:兩組治療前比較P=0.957(P0.05),差異無統(tǒng)計(jì)學(xué)意義,具有齊同可比性。兩組治療后分別進(jìn)行治療前后比較P=0.000(P0.01),差異有統(tǒng)計(jì)學(xué)意義,說明兩組藥物均能使臨床癥狀改善。且兩組治療后比較P=0.044(P0.05)差異有統(tǒng)計(jì)學(xué)意義,說明治療組對(duì)臨床癥狀的改善優(yōu)于對(duì)照組。4.子宮內(nèi)膜厚度比較:兩組治療前比較P=0.987(P0.05),差異無統(tǒng)計(jì)學(xué)意義,具有齊同可比性。兩組治療后分別進(jìn)行治療前后比較P=0.000(P0.01),差異有統(tǒng)計(jì)學(xué)意義,說明兩組藥物均能促進(jìn)子宮內(nèi)膜的增生和修復(fù)。兩組治療后比較,P=0.146(P0.05),差異無統(tǒng)計(jì)學(xué)意義,說明兩組藥物對(duì)子宮內(nèi)膜的增生和修復(fù)作用相當(dāng)。5.BBT:兩組患者治療前后基礎(chǔ)體溫均呈雙相,說明兩組對(duì)BBT影響不明顯。6.安全性及不良反應(yīng):兩組患者治療前后均未出現(xiàn)任何的不良反應(yīng)。結(jié)論1.兩組均能通過增加月經(jīng)量,改善臨床癥狀及使子宮內(nèi)膜增厚來達(dá)到治療的目的。2.兩組在增加子宮內(nèi)膜厚度上無差異,但在增加月經(jīng)量,改善臨床癥狀及總療效方面,服用王氏術(shù)黃調(diào)經(jīng)合劑的治療組療效均優(yōu)于服用夏氏健脾溫腎湯的對(duì)照組。
[Abstract]:Objective to observe the clinical effect of Wang's zhuangtiaojing mixture in treating menorrhagia due to deficiency of spleen and kidney, and to provide theoretical support and scientific basis for clinical application. Methods according to the standard, 80 patients were randomly divided into treatment group (n = 40) and control group (n = 40). The two groups were treated with one menstrual cycle and three courses of treatment. The recovery of menstrual volume, improvement of clinical symptoms and signs, changes of BBT in endometrium and side effects of drugs were observed before and after treatment. Result 1. Comparison of the total clinical efficacy: after three courses of treatment, the total effective rate of the treatment group was 97.5 and the total effective rate of the control group was 92.5. The total clinical efficacy of the two groups was compared with that of the two groups. The difference was statistically significant, and the treatment group was better than the control group. Comparison of menstrual volume score: before treatment, there was no significant difference between the two groups. The difference between the two groups before and after treatment was statistically significant, indicating that both groups could increase the menstrual volume. The difference between the two groups after treatment was statistically significant, indicating that the increase of menstrual volume in the treatment group was better than that in the control group. 3. Comparison of TCM syndromes integral: two groups were compared before treatment, the difference was not statistically significant and comparable. The difference between the two groups before and after treatment was statistically significant, which indicated that the two groups could improve the clinical symptoms. The difference between the two groups after treatment was statistically significant, indicating that the improvement of clinical symptoms in the treatment group was better than that in the control group. 4. Comparison of endometrial thickness: there was no significant difference in endometrial thickness between the two groups before treatment. After treatment, the two groups were compared before and after treatment, the difference was statistically significant, indicating that the two groups of drugs can promote the proliferation and repair of endometrium. There was no significant difference between the two groups after treatment, indicating that the two groups had the same effect on endometrial hyperplasia and repair. 5. BBT: the basic body temperature of the two groups was biphasic before and after treatment, indicating that the two groups had no significant effect on BBT. 6. Safety and adverse reactions: there were no adverse reactions in both groups before and after treatment. Conclusion 1. Both groups were able to achieve treatment by increasing menstrual volume, improving clinical symptoms and thickening the endometrium. There was no difference between the two groups in increasing endometrial thickness, but in increasing menstrual volume, improving clinical symptoms and total curative effect, the curative effect of the treatment group taking Wang's Shuzhu Huang Tiaojing mixture was better than that of the control group taking Xia's Jianpi Wenshen decoction.
【學(xué)位授予單位】：山西中醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R271.111

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 路云霞;;中西醫(yī)結(jié)合治療人工流產(chǎn)術(shù)后月經(jīng)過少療效觀察[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2016年02期

2 胡云飛;徐國(guó)兵;;牡丹皮及其主要成分丹皮酚的藥理作用研究進(jìn)展[J];安徽醫(yī)藥;2014年04期

3 周娜;黃可佳;;論補(bǔ)腎調(diào)周法治療月經(jīng)過少[J];遼寧中醫(yī)藥大學(xué)學(xué)報(bào);2014年02期

4 李仁國(guó);;柴胡有效成分及藥理作用分析[J];陜西中醫(yī);2013年06期

5 于海英;李軍;;蒼附導(dǎo)痰湯治療月經(jīng)過少[J];山西中醫(yī);2013年03期

6 王金權(quán);梁雨;王乾平;;復(fù)方玄駒膠囊治療腎陽虛型黃體功能不全不孕癥療效評(píng)價(jià)[J];光明中醫(yī);2013年01期

7 趙曉薇;楊可可;曾敏慧;張慶文;;張慶文教授治療虛證月經(jīng)過少的臨床經(jīng)驗(yàn)[J];四川中醫(yī);2012年11期

8 陳峗;錢菁;盧蘇;夏桂成;;初探夏桂成教授治療卵巢儲(chǔ)備功能低下性不孕癥臨證經(jīng)驗(yàn)[J];遼寧中醫(yī)藥大學(xué)學(xué)報(bào);2012年11期

9 楊娥;鐘艷梅;馮毅凡;;白術(shù)化學(xué)成分和藥理作用的研究進(jìn)展[J];廣東藥學(xué)院學(xué)報(bào);2012年02期

10 黃素英;;蔡小蓀辨治婦科疾病的創(chuàng)新思維[J];上海中醫(yī)藥大學(xué)學(xué)報(bào);2011年05期

相關(guān)會(huì)議論文 前2條

1 張玉珍;羅頌平;;羅元愷教授調(diào)經(jīng)、助孕、安胎的學(xué)術(shù)思想與臨床經(jīng)驗(yàn)[A];第九次全國(guó)中醫(yī)婦科學(xué)術(shù)大會(huì)論文集[C];2009年

2 王乾平;趙紅;;山西平遙王氏婦科治療不孕癥經(jīng)驗(yàn)[A];第九次全國(guó)中醫(yī)婦科學(xué)術(shù)大會(huì)論文集[C];2009年

相關(guān)碩士學(xué)位論文 前2條

1 溫錢杏;月經(jīng)過少的相關(guān)危險(xiǎn)因素調(diào)查[D];廣州中醫(yī)藥大學(xué);2012年

2 何晶瑩;柏子仁丸加澤蘭湯治療腎虛型月經(jīng)過少的臨床觀察[D];長(zhǎng)春中醫(yī)藥大學(xué);2012年

，

本文編號(hào)：2043737